Heart Rhythm

Hearts should have normal rhythm to their beats, but when these beats are out of synch, it causes inefficient pumping of blood. Irregular heart arrhythmias occur when the electrical signals that coordinate the heart's beats do not work properly. This can cause beats that are too fast (tachycardia), or too slow (bradycardia). Tachycardias include atrial fibrillation (AFib), supraventricular tachycardia, ventricular fibrillation, and ventricular tachycardia (VT). Bradycardias include sick sinus syndrome and conduction block. Electrophysiology arrhythmia treatments include medications, life style changes, and the EP lab interventions of catheter ablation, and implantable pacemakers or defibrillators.

Biosense Webster Varipulse PFA system performs well with minimal adverse events
"This was the first PFA IDE study to support a substantial number of fluoro-free procedures," said presenter Vivek Reddy, MD.
Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M
Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.
PaceMate names former Philips, BioTelemetry leader its new chief commercial officer
JR Finkelmeier has more than 20 years of experience in the healthcare and medical device industries.
Medtronic adds new AI models to its insertable cardiac monitors
The new algorithms are automatically applied in the cloud; patients wearing the devices are not required to take any additional steps.
World’s first dual-chamber leadless pacemaker still going strong after 6 months
Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

Previously Invisible Long QT Syndrome Now Observable With Machine Learning

MOUNTAIN VIEW, Calif., May 10, 2018 — AliveCor, the leader in artificial intelligence and FDA-cleared personal electrocardiogram (ECG) technology, today announced an important milestone in its work with Mayo Clinic on Long QT Syndrome (LQTS).

May 11, 2018

PTSD linked to higher AFib risk in young veterans

An analysis of more than one million post-9/11 veterans suggests a new diagnosis of post-traumatic stress disorder (PTSD) is associated with a greater likelihood of developing atrial fibrillation (AF). The study is scheduled to be presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.

May 10, 2018

Watchman implantation in AFib patients cost-effective for recurrent stroke prevention

Occluding the left atrial appendage with the Watchman device proved to be a cost-effective strategy for the secondary prevention of stroke among patients with atrial fibrillation (AFib), according to an analysis published in Stroke.

May 10, 2018

Medtronic’s Micra pacemaker associated with few complications in real-world analysis

Medtronic’s Micra Transcatheter Pacing System (TPS) demonstrated a major complication rate of 2.7 percent through one year, according to data from a post-approval registry that will be presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.

May 9, 2018

Bardy Diagnostics™ Announces Validation of AI-Enabled Automatic Screening Technology for Atrial Fibrillation

SEATTLE, May 9, 2018 — Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor ("CAM™"), the world's only P-wave centric™ ambulatory cardiac patch monitor and arrhythmia detection device, presented a poster today titled "Artificial Intelligence for the Automatic Detection of Atrial Fibrillation" at the Heart Rhythm Society 39th Annual Scientific Sessions that described a validated artificial intelligence-enabled (AI) screening technology to detect atrial fibrillation (AF) events.

May 9, 2018

First Cardiac Procedure Using the AcQMap® System by Acutus Medical® Successfully Performed in the United States

CARLSBAD, Calif., May 8, 2018 — Acutus Medical®, a global heart rhythm technology company, today announced that the AcQMap® High Resolution Imaging and Mapping System has been utilized for the first time in U.S. patients.

May 8, 2018

Penn Medicine performs 1st ablation with imaging aid in US

An intraoperative imaging and mapping system designed to aid in the ablation of complex cardiac arrhythmias was successfully used for the first time in the United States, according to an article distributed by Penn Medicine.

May 4, 2018

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

ABBOTT PARK, Ill., May 3, 2018 — Abbott (NYSE: ABT) today announced U.S. Food and Drug Administration (FDA) clearance of the Advisor™ HD Grid Mapping Catheter, Sensor Enabled™. Advisor HD Grid employs a new design that allows physicians to see things differently, capturing and analyzing data in a novel manner to create highly detailed maps of the heart that better differentiate healthy from unhealthy tissue.

May 4, 2018

Heart Rhythm

Biosense Webster Varipulse PFA system performs well with minimal adverse events

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

Medtronic adds new AI models to its insertable cardiac monitors

World’s first dual-chamber leadless pacemaker still going strong after 6 months